CAS: 475489-16-8 - AEW-541
Formula:C27H29N5O
InChI:InChI=1/C27H29N5O/c28-26-25-24(21-8-4-9-23(14-21)33-17-19-6-2-1-3-7-19)16-32(27(25)30-18-29-26)22-12-20(13-22)15-31-10-5-11-31/h1-4,6-9,14,16,18,20,22H,5,10-13,15,17H2,(H2,28,29,30)/t20-,22+
InChI key:InChIKey=AECDBHGVIIRMOI-GRGXKFILNA-N
SMILES:N=1C=NC2=C(C1N)C(=CN2C3CC(CN4CCC4)C3)C=5C=CC=C(OCC=6C=CC=CC6)C5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | AVP-AEW541 REF: IN-DA00DB74CAS: 475489-16-8 | 98% | To inquire | Mon 13 Jan 25 |
 | NVP-AEW541 REF: TM-T6080CAS: 475489-16-8 | 96.03% - 99.55% | To inquire | Tue 21 Jan 25 |
 | NVP-AEW541 REF: TR-N925640CAS: 475489-16-8 | - - - | 143.00 € | Tue 25 Feb 25 |
 | NVP-AEW541 REF: 3D-AUA48916CAS: 475489-16-8 | Min. 95% | To inquire | Mon 24 Feb 25 |
Ref: IN-DA00DB74
| 1mg | 115.00 € | ||
| 5mg | 296.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
NVP-AEW541
CAS:475489-16-8
NVP-AEW541 (AEW541), a potent inhibitor of IGF-1R(IC50=150 nM) and InsR(IC50=140 nM), exhibits excellent efficiency and …
Formula:
C27H29N5O
Purity:
96.03% - 99.55%
Color and Shape:
Solid
Molecular weight:
439.55
- Inhibitors
- Tyrosine Kinase/Adaptors
- FLT
- IGF-1R
- See more categories
- Autophagy
Ref: TM-T6080
| 1mg | 48.00 € | ||
| 2mg | 64.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 149.00 € | ||
| 25mg | 267.00 € | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 95.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
NVP-AEW541
Controlled ProductCAS:475489-16-8
Formula:
C27H29N5O
Color and Shape:
Neat
Molecular weight:
439.55
Ref: TR-N925640
| 2500µg | 143.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025
NVP-AEW541
CAS:475489-16-8
NVP-AEW541 is a chemical inhibitor that has been shown to inhibit cellular transformation in vitro. …
Formula:
C27H29N5O
Purity:
Min. 95%
Molecular weight:
439.55 g/mol
Ref: 3D-AUA48916
| 25mg | 1,259.00 € | ||
| 50mg | 1,751.00 € |
Estimated delivery in United States, on Monday 24 Feb 2025
